-
1 Comment
Vectura Group plc is currently in a long term uptrend where the price is trading 18.2% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.6.
Finally, its free cash flow fell by 67.1% to $3M since the same quarter in the previous year.
Based on the above factors, Vectura Group plc gets an overall score of 2/5.
Exchange | F |
---|---|
CurrencyCode | EUR |
ISIN | None |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Beta | 0.45 |
---|---|
Dividend Yield | 22.% |
Market Cap | 1B |
PE Ratio | 8.32 |
Target Price | 173.4 |
Vectura Group plc engages in the development of pharmaceutical therapies for the treatment of airways-related diseases. Vectura Group plc was formerly known as Vectura Limited and changed its name to Vectura Group plc in June 2004. The company was incorporated in 1997 and is based in Wiltshire, United Kingdom. As of October 19, 2021, Vectura Group plc operates as a subsidiary of PMI Global Services, Inc.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for V4TA.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025